BlackRock’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,561,931
Closed -$295K 5390
2024
Q1
$295K Sell
1,561,931
-10,654
-0.7% -$2.42K ﹤0.01% 4509
2023
Q4
$256K Sell
1,572,585
-66,404
-4% -$22K ﹤0.01% 4578
2023
Q3
$725K Buy
1,638,989
+197,922
+14% +$90.3K ﹤0.01% 4330
2023
Q2
$532K Sell
1,441,067
-5,194,875
-78% -$4.43M ﹤0.01% 4465
2023
Q1
$12.1M Sell
6,635,942
-181,529
-3% -$395K ﹤0.01% 3217
2022
Q4
$14.1M Buy
6,817,471
+227,471
+3% +$719K ﹤0.01% 3215
2022
Q3
$19.8M Buy
6,590,000
+1,247,012
+23% +$4.42M ﹤0.01% 3034
2022
Q2
$17.1M Buy
5,342,988
+4,662,830
+686% +$25.3M ﹤0.01% 3167
2022
Q1
$4.39M Buy
680,158
+57,458
+9% +$520K ﹤0.01% 4038
2021
Q4
$8.35M Buy
622,700
+615,700
+8,796% +$6.77M ﹤0.01% 3777
2021
Q3
$83K Buy
+7,000
New +$110K ﹤0.01% 5183

Other funds holding HLTH

BlackRock's HLTH Position: Q2 2024 in Review

BlackRock sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 1,561,931 shares — an estimated $295K sold.

BlackRock first reported a position in HLTH in Q3 2021 and held it in 11 quarters. The position peaked at $19.8M in Q3 2022. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • BlackRock reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • BlackRock sold 1,561,931 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $295K.
  • BlackRock first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • BlackRock's Cue Health Inc. Common Stock position peaked at $19.8M in Q3 2022.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.